Filing Details
- Accession Number:
- 0001209191-20-053885
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-05 19:00:54
- Reporting Period:
- 2020-10-01
- Accepted Time:
- 2020-10-05 19:00:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1527753 | Personalis Inc. | PSNL | Services-Medical Laboratories (8071) | 275411038 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1779787 | Richard Chen | C/O Personalis, Inc. 1330 O'Brien Drive Menlo Park CA 94025 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-10-01 | 37,452 | $0.44 | 152,750 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-10-01 | 13,472 | $21.67 | 139,278 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-10-01 | 26,528 | $22.26 | 112,750 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-10-01 | 37,452 | $0.00 | 37,452 | $0.44 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
71,884 | 2022-03-07 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The weighted average sale price for the transaction reported was $21.67, and the range of prices was between $21.03 and $22.02. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $22.26, and the range of prices was between $22.10 and $22.54. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- The shares subject to the option are fully vested and exercisable.